VIDEANT / ISRCTN43578978

Study ID(s) and Acronym(s)
ISRCTN43578978 // LT 44-076 // VIDEANT
Current Status of Trial
Completed
Study Aim
Treatment Dementia
Study Design
RCT
Blinding
Unclear
Intervention type
Non-pharmacological
Intervention
Staff Training//Treatment as Usual
Dosage and Duration
18 care centres in Berlin will be randomised to the intervention or control conditions: Intervention centres: 20 hours of training for nursing staff on causes, symptomatology and treatment of neuropsychiatric symptoms in dementia; 4 hours of training for primary care psychiatrists on causes and medical treatment of neuropsychiatric symptoms in dementia; 15 minute individual occupational therapy sessions twice a week; Provision of and training in standardized assessments of neuropsychiatric symptoms in dementia (nursing staff)//Control centres: treatment as usual
Absolute Number of Participants
400
Health Status/Diagnosis
Dementia
Main Diagnostic Criteria
Unclear
Co-morbid Health Condition/Other Participant Characteristics
Neuropsychiatric symptoms in dementia
Country or Countries of Recruitment
Germany
Unit of Allocation and/or Setting
18 Nursing homes in Berlin
Study start date
Study start date: November 2008//Estimated study completion date: May 2010
Primary outcomes
Primary Outcome Measures: Agitation as measured with the Cohen-Mansfield Agitation inventory (CMAI); Depression as measured with the Dementia Mood Assessment Scale (DMAS); Apathy as measured with the Apathy Evaluation Scale (AES)//Secondary Outcome Measures: Psychotropic medication in defined daily dosages; Number of hospital admissions; Caregiver burden as measured with the Perceived Stress Scale (PSS); Mortality
Key Points
A cluster RCT